Susquehanna International Group
SBIO icon

Susquehanna International Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Susquehanna International Group’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,600
Closed -$450K – 13080
2024
Q1 		$450K Buy
12,600
+5,500
+77% +$190K ﹤0.01% 8752
2023
Q4 		$234K Sell
7,100
-4,100
-37% -$110K ﹤0.01% 10355
2023
Q3 		$305K Sell
11,200
-8,200
-42% -$247K ﹤0.01% 9309
2023
Q2 		$612K Buy
+19,400
New +$603K ﹤0.01% 7843
2023
Q1 		– Sell
-8,300
Closed -$252K – 13378
2022
Q4 		$252K Sell
8,300
-1,000
-11% -$30.1K ﹤0.01% 9526
2022
Q3 		$280K Sell
9,300
-8,700
-48% -$275K ﹤0.01% 9966
2022
Q2 		$498K Sell
18,000
-9,500
-35% -$271K ﹤0.01% 8270
2022
Q1 		$925K Sell
27,500
-600
-2% -$20.8K ﹤0.01% 7326
2021
Q4 		$1.19M Buy
28,100
+5,700
+25% +$254K ﹤0.01% 6839
2021
Q3 		$1.02M Sell
22,400
-200
-0.9% -$9.18K ﹤0.01% 7517
2021
Q2 		$1.11M Sell
22,600
-14,500
-39% -$695K ﹤0.01% 7490
2021
Q1 		$1.86M Buy
37,100
+7,700
+26% +$426K ﹤0.01% 6090
2020
Q4 		$1.51M Buy
29,400
+8,900
+43% +$423K ﹤0.01% 5733
2020
Q3 		$843K Buy
20,500
+7,500
+58% +$309K ﹤0.01% 6533
2020
Q2 		$544K Buy
13,000
+4,200
+48% +$166K ﹤0.01% 7192
2020
Q1 		$279K Sell
8,800
-72,000
-89% -$2.75M ﹤0.01% 8115
2019
Q4 		$3.42M Buy
80,800
+16,600
+26% +$616K ﹤0.01% 3500
2019
Q3 		$2.03M Buy
64,200
+6,500
+11% +$228K ﹤0.01% 4158
2019
Q2 		$2.08M Buy
57,700
+12,100
+27% +$417K ﹤0.01% 4091
2019
Q1 		$1.65M Buy
45,600
+27,100
+146% +$905K ﹤0.01% 4064
2018
Q4 		$521K Buy
18,500
+10,800
+140% +$358K ﹤0.01% 5966
2018
Q3 		$303K Sell
7,700
-10,300
-57% -$391K ﹤0.01% 7470
2018
Q2 		$671K Sell
18,000
-13,400
-43% -$486K ﹤0.01% 6212
2018
Q1 		$1.07M Buy
31,400
+13,200
+73% +$463K ﹤0.01% 5077
2017
Q4 		$597K Buy
18,200
+2,800
+18% +$87.6K ﹤0.01% 6298
2017
Q3 		$480K Buy
15,400
+1,800
+13% +$52.8K ﹤0.01% 6576
2017
Q2 		$379K Sell
13,600
-1,200
-8% -$31.2K ﹤0.01% 7152
2017
Q1 		$381K Buy
14,800
+1,000
+7% +$24.9K ﹤0.01% 6977
2016
Q4 		$316K Sell
13,800
-3,900
-22% -$93.4K ﹤0.01% 7875
2016
Q3 		$462K Sell
17,700
-9,700
-35% -$242K ﹤0.01% 6199
2016
Q2 		$620K Buy
+27,400
New +$651K ﹤0.01% 5765

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Susquehanna International Group's SBIO Position: Q1 2026 in Review

Susquehanna International Group opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026: 60,686 shares worth $3.18M. The stake represents ﹤0.01% of the portfolio and ranks #5161 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in SBIO as recently as Q3 2025.

Susquehanna International Group first reported a position in SBIO in Q2 2015 and has held it in 33 quarters since. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

  • Susquehanna International Group held 60,686 shares of ALPS Medical Breakthroughs ETF worth $3.18M as of Q1 2026.
  • ALPS Medical Breakthroughs ETF was a new Susquehanna International Group position in Q1 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5161 holding.
  • Susquehanna International Group first reported a position in ALPS Medical Breakthroughs ETF in Q2 2015 and has held it in 33 quarters since.
  • 59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.